This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

ACIP Recommendations for Use of Seasonal Influenza Vaccines

The Aug. 7, 2015 issue of the CDC's Morbidity and Mortality Weekly Report (MMWR) provides a report that updates the 2014 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines. Updated information for the 2015-16 season includes:

- Antigenic composition of U.S. seasonal influenza vaccines

- Information on influenza vaccine products expected to be available for the 2015-16 season

- An updated algorithm for determining the appropriate number of doses for children aged 6 months through 8 years

- Recommendations for the use of live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) when either is available, including removal of the 2014-15 preferential recommendation for LAIV for healthy children aged 2 through 8 years.

To read further from the MMWR report, CLICK HERE.

Reference: Grohskopf LA, Sokolow LZ,  Olsen SJ,  Bresee JS, Broder KR and Karron RA. Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season. MMWR. Aug. 7, 2015; 64(30);818-825

comments powered by Disqus